Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs ...

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...

GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity.

Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.